Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FWHP4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,986
Award facts
- Contract value 100% obligated
- $10,985.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Rexulti 2 mg tablets (30-count) with a ceiling value of $10,985.91. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The award is structured as a child contract under AmerisourceBergen's parent organization, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026.
This delivery order falls under DLA's pharmaceutical supply framework, which supports military healthcare systems and federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, regularly fulfilling government requirements for prescription medications across multiple therapeutic domains. Rexulti (brexpiprazole) is an atypical antipsychotic medication commonly used in military and veteran healthcare settings for treating psychiatric conditions. The contract demonstrates the contractor's capability to efficiently deliver specialty pharmaceuticals to support government healthcare operations on a competitive, firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DR26FWHP4?
SPE2DR26FWHP4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FWHP4 worth?
The government has obligated $10,986 on SPE2DR26FWHP4.
Is contract SPE2DR26FWHP4 an order under another contract?
Yes. SPE2DR26FWHP4 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHP4 competed?
The extent of competition for SPE2DR26FWHP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award